RSS-Feed abonnieren
DOI: 10.1055/a-2010-7244
Chirurgische Interventionen beim Morbus Paget
Surgical Interventions in Paget DiseaseZusammenfassung
Die orthopädisch – chirurgische Behandlung von Patienten mit einem Morbus Paget stellt eine Herausforderung dar.
In der modernen orthopädischen Chirurgie stehen adäquate Verfahren zur Verfügung, um – korrekt eingesetzt – dem Patienten eine deutliche Reduktion seiner Beschwerden zu ermöglichen und die Lebensqualität zu verbessern. Die Hauptkomplikationen sind pathologische Frakturen, Deformitäten der befallenen Knochen und die frühzeitige Entwicklung einer sekundären Arthrose großer Gelenke.
Für den Operateur zu beachten, dass dieses Patientengut mit einem erhöhten Risiko für intra- und postoperative Komplikationen einhergeht. Um die Komplikationsraten weitgehend zu minimieren bedarf es einer sorgfältigen präoperativen Planung mit Überprüfung des aktuellen Status der Grunderkrankung und möglicher präoperativer medikamentöser Intervention mittels Bisphosphonaten (evidenzbasiert Zoledronat 5 mg) zur Normalisierung des Knochenstoffwechsels. Auch muss eine umfassende klinische und radiologische Diagnostik durchgeführt werden, um mögliche Mitbeteiligungen angrenzender Skelettabschnitte frühzeitig zu erkennen und Operationen und Implantate planen zu können.
Intraoperativ sind die Schwierigkeiten gekennzeichnet durch die erhöhte Vaskularisierung des betroffenen Knochens und die deutlich veränderte Knochenstruktur. Einem vermehrten Blutverlust kann durch eine rechtzeitig eingeleitete Bisphosphonat-Therapie wahrscheinlich vorgebeugt werden. Wegen des oft gleichzeitig vorliegenden sklerotischen und osteolytischen Knochens ist die Verwendung geeigneten Instrumentarien und besondere Sorgfalt bei der Implantation von Osteosynthesematerial und Endoprothesen geboten. Eine maligne Entartung sollte bei ausgeprägter Schmerzsymptomatik und Weichteilschwellung bis zu ihrem Ausschluss in Betracht gezogen werden und eine weitere Diagnostik eingeleitet werden.
Abstract
The orthopedic-surgical treatment of patients with Paget's disease is a challenge.
In modern orthopedic surgery, adequate procedures are available to enable the patient – correctly applied – to significantly reduce his or her complaints and improve the quality of life. The main complications are pathological fractures, deformities of the affected bones and the early development of secondary arthrosis.
For the surgeon to consider, this patient population is associated with an increased risk of intraoperative and postoperative complications. In order to minimize complication rates to a large extent, careful preoperative planning with review of the current status of the underlying disease and possible preoperative drug intervention using bisphosphonates (evidence-based zoledronate 5 mg) to normalize bone metabolism is required. Comprehensive clinical and radiological diagnostics must also be performed to identify possible involvement of adjacent skeletal segments early and to plan surgery and implants.
Intraoperative difficulties are characterized by the increased vascularization of the affected bone and the significantly altered bone structure. Increased blood loss can probably be prevented by timely initiation of bisphosphonate therapy. Because of the often concomitant presence of sclerotic and osteolytic bone, the use of appropriate instrumentation and special care in the implantation of osteosynthesis materials and endoprostheses is required. Malignant transformation should be considered until ruled out in cases of increaded pain symptoms and soft tissue swelling, and further diagnostics should be initiated.
Publikationsverlauf
Eingereicht: 04. November 2022
Angenommen: 09. Januar 2023
Artikel online veröffentlicht:
28. Februar 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Paget J.. On a Form of Chronic Inflammation of Bones (Osteitis Deformans). Med Chir Trans 1877; 60: 37-64.9
- 2 Gennari L, Rendina D, Falchetti A, Merlotti D. Paget’s disease of bone. Calcif Tissue Int 2019; 104: 500
- 3 Gennari L, Rendina D, Picchioni T. et al. Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy. Expert Opin Orphan. Drugs 2018; 6: 485-496
- 4 Monfort J, Rot’esSala D, Romero AB. et al. Epidemiological, clinical, biochemical, and imaging characteristics of monostotic and polyostotic Paget’s disease. Bone 1999; 24: 13S-14S
- 5 Gamble G, Wattie D, Rutland M, Cundy T.. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 2004; 75: 358-64
- 6 Poor G, Donath J, Fornet B, Cooper C.. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006; 21: 1545-929
- 7 Britton C, Brown S, Ward L, Rea SL, Ratajczak T, Walsh JP.. The changing presentation of Paget’s disease of bone in Australia, a high prevalence region. Calcif Tissue Int 2017; 101: 564-9
- 8 Renier JC, Audran M. Progression in length and width of pagetic lesions, and estimation of age at disease onset. Rev Rhum Engl Ed 1997; 64: 35-43
- 9 Maldague B, Malghem J. Dynamic radiologic patterns of Paget’s disease of bone. Clin Orthop Relat Res 1987; 217: 126-51
- 10 Hamadouche M, Mathieu M, Topouchian V. et al. Transfer of Paget’s disease from one part of the skeleton to another as a result of autogenous bone grafting: a case report. J Bone Joint Surg Am 2002; 84: 2056-61
- 11 Al Nofal AA, Altayar O, BenKhadra K. et al. Bone turnover markers in Paget’s disease of the bone: a systematic review and meta analysis. Osteoporosis Int 2015; 26: 1875-1891
- 12 Mirra JM, Brien EW, Tehranzadeh J.. Paget’s disease of bone: review with emphasis on radiologic features, Part II. Skeletal Radiol 1995; 24: 173-84
- 13 Reid IR, Lyles K, Su G. et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res 2011; 26: 2261-70 66
- 14 Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH.. Bisphosphonates for Paget’s disease of bone in adults. Cochrane Database Syst Rev 2017; 12
- 15 Ralston SH, Corral-Gudino L, Cooper C. et al. Clinical guidelines on Paget’s disease of bone. J Bone Miner Res 2019; 34: 2327-2329
- 16 Wegrzyn J, Pibarot V, Chapurlat R, Carret JP, Bejui-Hugues J, Guyen O.. Cementless total hip arthroplasty in Paget’s disease of bone: a retrospective review. Int Orthop 2010; 34: 1103-9
- 17 Gabel GT, Rand JA, Sim FH.. Total knee arthroplasty for osteo arthrosis in patients who have Paget disease of bone at the knee. J Bone Joint Surg Am 1991; 73: 739-44
- 18 Lee GC, Sanchez-Sotelo J, Berry DJ.. Total knee arthroplasty in patients with Paget’s disease of bone at the knee. J Arthroplasty 2005; 20: 689-93
- 19 Jorge-Mora A, Amhaz-Escanlar S, Lois-Iglesias A, Leborans-Eiris S, Pino-Minguez J.. Surgical treatment in spine Paget’s disease: a systematic review. Eur J Orthop Surg Traumatol 2016; 26: 27-30
- 20 Parvizi J, Frankle MA, Tiegs RD, Sim FH.. Corrective osteotomy for deformity in Paget disease. J Bone Joint Surg Am 2003; 85-A: 697-702
- 21 Whyte MP.. Clinical practice. Paget’s disease of bone. N Engl J Med 2006; 355: 593-600126
- 22 Nicholas JA, Killoran P.. Fracture of the femur in patients with Paget’s disease; results of treatment in twenty-three cases. J Bone Joint Surg Am 1965; 47: 450-61
- 23 127. Verinder DG, Burke J.. The management of fractures in Paget’s disease of bone. Injury. 1979; 10: 276-80
- 24 Grundy M.. Fractures of the femur in Paget’s disease of bone. Their etiology and treatment. J Bone Joint Surg Br 1970; 52: 252-63
- 25 Bradley CM, Nade S.. Outcome after fractures of the femur in Paget’s disease. Aust N Z J Surg 1992; 62: 39-44
- 26 Bidner S, Finnegan M.. Femoral fractures in Paget’s disease. J Orthop Trauma 1989; 3: 317-22
- 27 Parvizi J, Klein GR, Sim FH. Surgical management of Paget’s disease of bone. J Bone Miner Res 2006; 21: 75-82
- 28 McDonald DJ, Sim FH.. Total hip arthroplasty in Paget’s disease. A follow-up note. J Bone Joint Surg Am 1987; 69: 766-72
- 29 Parvizi J, Schall DM, Lewallen DG, Sim FH.. Outcome of uncemented hip arthroplasty components in patients with Paget’s disease. Clin Orthop Relat Res 2002; 403: 127-34
- 30 Hanna SA, Dawson-Bowling S, Millington S. et al. Total hip arthroplasty in patients with Paget’s disease of bone: a systematic review. World J Orthop 2017; 8: 357-363
- 31 Lewallen DG. Hip arthroplasty in patients with Paget’s disease. Clin Orthop Relat Res. 1999
- 32 Drake MT, Clarke BL, Khosla S.. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83: 1032-1045
- 33 Hurley E, Cashman J, Synnott K. et al. Cemented versus cementless total hip arthroplasty in Paget’s disease of bone: a systematic review. J Hip Surg 2017; 01: 087-092
- 34 Board TN, Karva A, Board RE, Gambhir AK, Porter ML.. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg Br 2007; 89: 434-440
- 35 Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnik CS, Gannon FH.. From the archives of the AFIP. Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics 2002; 22: 1191-1216
- 36 Schai PA, Scott RD, Younger AS.. Total knee arthroplasty in Paget’s disease: technical problems and results. Orthopedics 1999; 22: 21-25
- 37 Roper BA.. Paget’s disease at the hip with osteoarthrosis: results of intertrochanteric osteotomy. J Bone Joint Surg Br 1971; 53: 660-2
- 38 Mankin HJ, Hornicek FJ. Paget’s sarcoma: A historical and outcome review. Clin Orthop Relat Res 2005; 438: 97-102 55
- 39 Ruggieri P, Calabro T, Montalti M, Mercuri M.. The role of surgery and adjuvants to survival in Pagetic osteosarcoma. Clin Orthop Relat Res 2010; 468: 2962-8